Lead compound MAP4343

• Highly Efficient : brings neuro-protection and neuro-plasticity (Neuro-traumatic injuries, Depression)
• Perfectly Safe  : positive human Phase 1
• Highly Specific  : no affinity for any CNS and steroid receptor
• Orphan Drug Status  : for treating Spinal Cord Injuries
• Oral & s.c formulations  : 2 formulations for 2 sets of indications
• New MoA : increases microtubules dynamics

… with Translational Biomarkers

Back-up molecules & new developments

•  Eight other candidates from first screening, MAP46 under investigation
• Capability to generate other derivatives on the same target